Protea Biosciences Revenue, Profits - PRGBQ Quarterly Income Statement

Add to My Stocks
$0.01 $0 (0%) PRGBQ stock closing price Sep 19, 2018 (Closing)

Financial analysis of Protea Biosciences involves more than just checking the Protea Biosciences stock price, by looking at the financial statements of the company in detail. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the PRGBQ stock is bound to reflect the impact of the QOQ decline of 0. The operating expenses as shown in the Protea Biosciences profit and loss statement for 2017 Q2 total to $1.11M. This line item shows that the operating expenses has decreased compared with last year. Also check: Protea Biosciences assets and Protea Biosciences free cash flow.

View and download details of revenue and profits for Protea Biosciences for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Protea Biosciences Revenues or Net Sales
Cost Of Goods Sold (COGS)-------
Protea Biosciences Gross Profit
Research & Development Expense-------
Selling General & Admin Expense1.11M1.49M--1.38M1.6M1.66M
Income Before Depreciation Depletion Amortization-1.37M-1.55M---1.43M-1.56M-1.61M
Depreciation Depletion Amortization-------
Non Operating Income-2.93M-3.84M-----
Interest Expense1.19M------
Protea Biosciences Pretax Income
Provision for Income Taxes-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-5.5M-5.87M-7.24M-5.52M-1.81M-1.09M-2M
Extraordinary Items & Discontinued Operations-------
Protea Biosciences Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS6.1M3.38M2.78M2.68M2.67M2.67M2.19M
Average Shares used to compute Basic EPS6.1M3.38M2.78M2.68M2.67M2.67M2.19M
Income Before Nonrecurring Items-5.5M-2.04M-1.48M-2.28M-1.81M-1.09M-2M
Income from Nonrecurring Items--3.83M-5.76M-3.24M---
Protea Biosciences Earnings Per Share Basic Net
Protea Biosciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-1.00-0.50-0.50-1.00-0.50-0.50-1.00
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our MEDPACE HLDGS financial analysis

Before investing one should read a report on Protea Biosciences stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this quarter of 2017 Q2. Our Protea Biosciences revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. PRGBQ stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The PRGBQ financials along with Protea Biosciences historical stock prices provide a lot of details about the firm.

Protea Biosciences Income Statement - Key Financial Ratios

Other Income Statements - Protea Biosciences Group Inc Industry Peers

MEDPACE HLDGS income statement